CapitalStars Financial Research Pvt Ltd


CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Saturday, 27 May 2017

Pharma shares lose nearly Rs 60,000 crore in one week - 27 May 2017

Sun Pharmaceutical

Investors in pharmaceutical companies have seen wealth erosion of nearly Rs 60,000 crore during the week after a sharp decline in market values of these stocks.

The combined market capitalisation (m-cap) of pharmaceutical companies, which featuring in Nifty Pharma and S&P BSE Healthcare index, has declined by Rs 59,411 crore to Rs 725,697 crore today at 02:45 pm. These companies had total m-cap of Rs 785,108 crore on Friday, May 19, 2017.

Nifty Pharma index trading at three-year low is set to report its biggest fall on weekly basis. The index decline 10.6% thus far in current week, its sharpest decline since October 2008.

Sun Pharmaceutical Industries, Lupin, Dr Reddy’s Laboratories, Aurobindo Pharma, Glenmark Pharmaceuticals and Novartis are notable stocks from 12 companies that hit 52-week lows during the week.

Sun Pharma, the largest loser among pharma stocks in term of m-cap erosion, lost Rs 19,722 crore m-cap in single week. The stock hit a 52-week low of Rs 568 on BSE in intra-day trade today. It tanked 13% after Sun Pharma’s US subsidiary Taro Pharma reported 26% dip in March 2017 quarter (Q4FY17) net sales due to the intense pricing pressure in the US market. Sun Pharma is scheduled to announce its March quarter earnings today.

Lupin, the largest loser in percentage terms, lost m-cap of Rs 9,101 crore. The stock dipped 15% from Rs 1,315 to Rs 1,113, its lowest level since August 2004. The company’s quarterly net profit nearly halved to Rs 380 crore in Q4FY17 from Rs 748 crore in a year ago quarter.

Cipla slipped 13%, lost m-cap of Rs 6,014 crore during the week. Cipla’s performance in 4QFY17 was disappointing, with revenues growing 8% YoY to Rs 360 crore, lower EBITDA margin of 14.1% (sequential decline of around 450bps) and net loss of Rs 60 crore.

Cpla’s India business performance was disappointing, declining 4% YoY. This was driven by de-stocking at the channel level. We believe that CIPLA’s low presence in fast-growing therapies like derma, CNS and anti-diabetics and high vulnerability to price cuts will restrict growth, analysts at HDFC Securities said in result review.

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


Post a Comment